These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34730710)

  • 1. Living conditions, seroprevalence and symptoms of COVID-19 in slums in the Metropolitan Region of Vitória (Espírito Santo).
    Maciel ELN; Jabor PM; Macedo LR; Almada GL; Zanotti RL; Cerutti Junior C; Gomes CC; Alencar FEC; Reuter T; Andrade VLG; Cardoso OA; Medeiros Junior NF; Bastos WM; Bertolani MN; Silva LT; Zandonade E
    Rev Bras Epidemiol; 2021; 24():e210048. PubMed ID: 34730710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection prevalence and associated factors: a serial population-based study in Espírito Santo, Brazil, May to June 2020.
    Cardoso OA; Gomes CC; Cerutti Junior C; Maciel ELN; Alencar FEC; Almada GL; Macedo LR; Silva LT; Medeiros Junior NF; Jabor PM; Zanotti RL; Reuter T; Andrade VLG; Bastos WM; Zandonade E
    Epidemiol Serv Saude; 2022; 31(2):e2022112. PubMed ID: 36043577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of SARS-CoV-2 antibodies in the State of Mato Grosso, Brazil: a population-based survey].
    Oliveira EC; Terças-Trettel ACP; Andrade ACS; Muraro AP; Santos ESD; Espinosa MM; Musis CR
    Cad Saude Publica; 2022; 38(5):e00093021. PubMed ID: 35703597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
    Lalwani P; Salgado BB; Filho IVP; da Silva DSS; de Morais TBDN; Jordão MF; Barbosa ARC; Cordeiro IB; Neto JNS; de Assunção EN; Dos Santos RO; Carvalho NO; Sobrinho WBS; da Costa CF; de Souza PE; de Albuquerque BC; Ganoza CA; Araujo-Castillo RV; Filho SA; Lalwani JDB;
    Int J Infect Dis; 2021 Sep; 110():141-150. PubMed ID: 34273518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
    Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
    Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
    Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
    PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Logistics Workers Are a Key Factor for SARS-CoV-2 Spread in Brazilian Small Towns: Case-Control Study.
    Bernardes-Souza B; Júnior SRC; Santos CA; Neto RMDN; Bottega FC; Godoy DC; Freitas BL; Silva DLG; Brinker TJ; Nascimento RA; Tupinambás U; Reis AB; Coura-Vital W
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30406. PubMed ID: 34388105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
    Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
    Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of COVID-19 infection in the prison system in Espírito Santo/Brazil: persons deprived of liberty and justice workers.
    Silva AID; Maciel ELN; Duque CLC; Gomes CC; Bianchi EDN; Cardoso OA; Lira P; Jabor PM; Zanotti RL; Sá RT; Magno Filho SJS; Zandonade E
    Rev Bras Epidemiol; 2021 Sep; 24():e210053. PubMed ID: 34877995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2 Infection among Occupational Groups from the Bucaramanga Metropolitan Area, Colombia.
    Colmenares-Mejía CC; Serrano-Díaz N; Quintero-Lesmes DC; Meneses L; Salazar Acosta I; Idrovo ÁJ; Sanabria-Echeverry DY; Cordero-Rebolledo H; Castillo V
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33920843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
    BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.
    Pontes GS; de Melo Silva J; Pinheiro-Silva R; Barbosa AN; Santos LC; de Pádua Quirino Ramalho A; de Castro Alves CE; da Silva DF; de Oliveira LC; da Costa AG; Bruno AC
    Sci Rep; 2021 Sep; 11(1):17534. PubMed ID: 34475438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.
    Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL;
    Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
    Biggs HM; Harris JB; Breakwell L; Dahlgren FS; Abedi GR; Szablewski CM; Drobeniuc J; Bustamante ND; Almendares O; Schnall AH; Gilani Z; Smith T; Gieraltowski L; Johnson JA; Bajema KL; McDavid K; Schafer IJ; Sullivan V; Punkova L; Tejada-Strop A; Amiling R; Mattison CP; Cortese MM; Ford SE; Paxton LA; Drenzek C; Tate JE;
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):965-970. PubMed ID: 32701941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome coronavirus 2019. Seroepidemiology study in Argentinian slum.
    Figar S; Pagotto V; Luna L; Salto J; Wagner Manslau M; Mistchenko AS; Gamarnik A; Gómez Saldaño AM; González Bernaldo de Quirós F
    Medicina (B Aires); 2021; 81(2):135-142. PubMed ID: 33906129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia.
    Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S
    Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.